Orthofix Medical Inc. (OFIX) stock
OFIXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 23
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/3049% below fair value
$7.17+0.23 (+3.31%)
Close on Nov 13, 2026Market cap $292.05MP/E –Yield –
Orthofix Medical total assets
Total assets on the balance sheet at the end of each period.
Orthofix Medical's total assets was $855.76M at Sep 30, 2026. For fiscal 2025 it was $850.65M, down 4.8% from the year before. Over ten years it grew 7.8% a year on average. The highest annual figure on record is $925.32M in fiscal 2023.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $850.65M | -4.8% |
| FY2024 | Dec 31, 2024 | $893.29M | -3.5% |
| FY2023 | Dec 31, 2023 | $925.32M | +101.8% |
| FY2022 | Dec 31, 2022 | $458.63M | -3.8% |
| FY2021 | Dec 31, 2021 | $476.62M | -9.4% |
| FY2020 | Dec 31, 2020 | $525.86M | +6.1% |
| FY2019 | Dec 31, 2019 | $495.62M | +6.2% |
| FY2018 | Dec 31, 2018 | $466.64M | +15.1% |
| FY2017 | Dec 31, 2017 | $405.35M | +8.9% |
| FY2016 | Dec 31, 2016 | $372.10M | -7.0% |
| FY2015 | Dec 31, 2015 | $400.22M | +1.8% |
| FY2014 | Dec 31, 2014 | $392.96M | -4.6% |
| FY2013 | Dec 31, 2013 | $411.98M | -11.3% |
| FY2012 | Dec 31, 2012 | $464.55M | -32.2% |
| FY2011 | Dec 31, 2011 | $685.38M | +13.5% |
| FY2010 | Dec 31, 2010 | $603.99M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $855.76M | +2.8% |
| Q2 FY2026 | Jun 30, 2026 | $873.02M | +4.3% |
| Q1 FY2026 | Mar 31, 2026 | $886.60M | +7.7% |
| Q4 FY2025 | Dec 31, 2025 | $850.65M | -4.8% |
| Q3 FY2025 | Sep 30, 2025 | $832.61M | -4.1% |
| Q2 FY2025 | Jun 30, 2025 | $837.16M | -5.1% |
| Q1 FY2025 | Mar 31, 2025 | $823.14M | -9.2% |
| Q4 FY2024 | Dec 31, 2024 | $893.29M | -3.5% |
| Q3 FY2024 | Sep 30, 2024 | $867.87M | -4.2% |
| Q2 FY2024 | Jun 30, 2024 | $882.00M | -2.1% |
| Q1 FY2024 | Mar 31, 2024 | $906.05M | -1.2% |
| Q4 FY2023 | Dec 31, 2023 | $925.32M | +101.8% |
| Q3 FY2023 | Sep 30, 2023 | $905.65M | +101.4% |
| Q2 FY2023 | Jun 30, 2023 | $901.29M | +95.2% |
| Q1 FY2023 | Mar 31, 2023 | $917.14M | +98.5% |
| Q4 FY2022 | Dec 31, 2022 | $458.63M | -3.8% |
| Q3 FY2022 | Sep 30, 2022 | $449.66M | -10.1% |
| Q2 FY2022 | Jun 30, 2022 | $461.66M | -8.0% |
| Q1 FY2022 | Mar 31, 2022 | $461.99M | -10.1% |
| Q4 FY2021 | Dec 31, 2021 | $476.62M | -9.4% |
| Q3 FY2021 | Sep 30, 2021 | $500.40M | -3.2% |
| Q2 FY2021 | Jun 30, 2021 | $502.01M | -15.7% |
| Q1 FY2021 | Mar 31, 2021 | $513.87M | +4.1% |
| Q4 FY2020 | Dec 31, 2020 | $525.86M | +6.1% |
| Q3 FY2020 | Sep 30, 2020 | $517.13M | +8.7% |
| Q2 FY2020 | Jun 30, 2020 | $595.71M | +21.9% |
| Q1 FY2020 | Mar 31, 2020 | $493.49M | +3.0% |
| Q4 FY2019 | Dec 31, 2019 | $495.62M | +6.2% |
| Q3 FY2019 | Sep 30, 2019 | $475.60M | +5.7% |
| Q2 FY2019 | Jun 30, 2019 | $488.81M | +10.6% |
| Q1 FY2019 | Mar 31, 2019 | $479.32M | +17.2% |
| Q4 FY2018 | Dec 31, 2018 | $466.64M | +15.1% |
| Q3 FY2018 | Sep 30, 2018 | $450.17M | +16.5% |
| Q2 FY2018 | Jun 30, 2018 | $441.76M | +20.2% |
| Q1 FY2018 | Mar 31, 2018 | $409.00M | +15.3% |
| Q4 FY2017 | Dec 31, 2017 | $405.35M | +8.9% |
| Q3 FY2017 | Sep 30, 2017 | $386.30M | – |
| Q2 FY2017 | Jun 30, 2017 | $367.68M | – |
| Q1 FY2017 | Mar 31, 2017 | $354.75M | – |
| Q4 FY2016 | Dec 31, 2016 | $372.10M | – |
See a number that looks wrong?